Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020097014 - ANTI-DIABETIC ACTIVITY OF NEEM EXTRACT AND SYNERGISTIC COMBINATIONS OF UROLITHINS A AND B

Publication Number WO/2020/097014
Publication Date 14.05.2020
International Application No. PCT/US2019/059774
International Filing Date 05.11.2019
IPC
A61K 36/58 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
58Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
B01D 11/02 2006.01
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
11Solvent extraction
02of solids
Applicants
  • NATREON, INC. [US]/[US]
Inventors
  • VEERARAGAVAN, Muruganandam, A.
  • SEN, Chandan, K.
  • KALIDINDI, Sanyasi, R.
Agents
  • CARRERA, George, M. Jr.
  • NEYMEYER-TYNKOV, Valerie
  • TALATI, Ashish
  • KRIT, Jonathan, J.
Priority Data
16/672,74304.11.2019US
20184104178805.11.2018IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-DIABETIC ACTIVITY OF NEEM EXTRACT AND SYNERGISTIC COMBINATIONS OF UROLITHINS A AND B
(FR) ACTIVITÉ ANTIDIABÉTIQUE D'EXTRAIT DE NEEM ET ASSOCIATIONS SYNERGIQUES D'UROLITHINES A ET B
Abstract
(EN)
Methods of treating symptoms of type 2 diabetes in a human subject by administering a composition comprising urolithin A and urolithin B, are provided. Methods of treating symptoms of type 2 diabetes and metabolic syndrome in a human subject by administering a composition comprising neem extract are provided.
(FR)
L'invention concerne des méthodes de traitement de symptômes du diabète de type 2 chez un sujet humain par l'administration d'une composition comprenant de l'urolithine A et de l'urolithine B. L'invention concerne également des méthodes de traitement de symptômes du diabète de type 2 et du syndrome métabolique chez un sujet humain par l'administration d'une composition comprenant de l'extrait de neem.
Also published as
Latest bibliographic data on file with the International Bureau